［1］   Heit JA，Cohen AT，Anderson FA．Estimated annual number of incidence and recurrent，non-fatal and fatal venous thromboembolism (VTE) events in the US［J］．Blood，2005，106：267A．

［2］    Martinez C，Cohen AT，Bamber L，et al．Epidemiology of first and recurrent venous thromboembolism：a population-based cohort study in patients without active cancer［J］．Thromb Haemost，2014，112(2)：255-263．

［3］    Stein PD，Matta F．Acute pulmonary embolism［J］．Curr Probl Cardiol，2010，35(7)：314-376．

［4］   Geerts WH，Bergqvist D，Pineo GF，et al．Prevention of venous thromboembolism：American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8thEdition)［J］．Chest，2008，133(6 suppl)：381S-453S．

［5］   Clarke-Pearson DL，Abaid LN．Prevention of venous thromboembolic events after gynecologic surgery［J］．Obstet Gynecol，2012，119(1)：155-167．

［6］    Bahl V，Hu HM，Henke PK，et al．A validation study of a retrospective venous thromboembolism risk scoring method［J］．Ann Surg，2010，251：344-350．

［7］   Committee on Practice Bulletins-Gynecology，American College of Obstetricians and Gynecologists．ACOG Practice Bulletin No.84.Prevention of deep vein thrombosis and pulmonary embolism［J］．Obstet Gynecol，2007，110(2 Pt 1)：429-440．

［8］    Ginzburg E，Cohn SM，Lopez J，et al．Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma．Miami Deep Vein Thrombosis Study Group［J］．Br J Surg，2003，90：1338-1344．

［9］    Hull RD，Pineo GF，Stein PD，et al．Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty：a systematic review［J］．Arch Intern Med，2001，161(16)：1952-1960．

［10］    Raskob GE，Hirsh J．Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery［J］．Chest，2003，124(suppl)：379S-385S．

（2014-07-10收稿    2014-08-10修回）